Neutrophil-to-lymphocyte ratio as a promising non-invasive biomarker for symptom assessment and diagnosis of interstitial cystitis/bladder pain syndrome

Table 4 Correlation coefficients between rating scales and urodynamic data with NLR in patients with IC/BPS

Characteristic	Overall	Spearson	P value
Medical history, months	64.76 ± 87.51	-0.111	0.366
Daytime voids, ml	19.22 ± 10.27	-0.06	0.63
Nighttime voids, ml	6.85 ± 3.67	0.268*	0.028
Total voids, ml	25.32 ± 12.22	-0.048	0.696
Average voided volumes, ml	152.18 ± 93.88	-0.018	0.898
VAS	5.46 ± 2.92	0.111	0.369
ICPI	11.97 ± 3.06	0.327**	0.007
ICSI	12.24 ± 4.29	0.369**	0.002
PUF Symptom Scale	13.42 ± 4.21	0.263*	0.032
PUF distress Scale	7.27 ± 2.82	0.205	0.096
PUF	20.69 ± 6.3	0.297*	0.015
OABSS	7.49 ± 2.7	0.184	0.137

Data are presented as mean ± SD, n (%), median (IQR). NLR, Neutrophil-to-lymphocyte ratio; VAS, Visual Analogue Scale/Score; ICSI, Interstitial Cystitis Symptom Index; ICPI, Interstitial Cystitis Problem Index; PUF, Pelvic Pain and Urgency/Frequency questionnaire; OABSS, overactive bladder syndrome score

ISSN: 1471-2490